1. | Kidney disease activity rating scales in systemic lupus erythematosus should include the following: |
 |   •A measure of estimated glomerular filtration rate (eGFR) |
 |    ◦Using consensus-based equation |
 |   •A measure of proteinuria |
 |    ◦Using 24-hour collection |
 |   •Analysis of urine sediment only in conjunction with above |
2. | Guidelines for future trials of lupus nephritis: |
 |   •Complete response should be a composite endpoint of the following: |
 |    ◦Proteinuria of less than 0.3 g/day |
 |    ◦eGFR: |
 |      ▪Stable (if more than 60 mL/min per m2 at baseline) or |
 |      ▪Improvement of at least 50% (if less than 60 mL/min per m2 at baseline) |
 |    ◦Consider repeat biopsy in patients meeting criteria for response or non-response |
 |    ◦Reduction or discontinuation of glucocorticoids |
 |   •Treatment failure should be a composite of the following: |
 |    ◦Need for renal replacement therapy or transplant |
 |    ◦Persistent doubling of serum creatinine |
 |    ◦eGFR decrease by at least 50% |
 |    ◦Renal flare requiring treatment |
 |    ◦Death |
 |   •Design should require 12 to 24 months of follow-up. |
 |   •Detailed guidance on steroid dosing should be provided. |